Player FM ऐप के साथ ऑफ़लाइन जाएं!
TBT - Cardiovascular Disease
Manage episode 429602517 series 3323674
Welcome back Rounds Table Listeners!
In this throwback episode, Drs. Mike and John Fralick discuss the use of semaglutide in patients with obesity without diabetes and changes in renal function after starting dapagliflozin in patients with heart failure. Check it out below!
- Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial (0:00 – 09:40).
- Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (09:40 – 19:24).
And for the Good Stuff:
- How Ozempic and Weight Loss Drugs Are Reshaping Denmark’s Economy (19:24 – 19:58).
- How a Canadian scientist and a venomous lizard helped pave the way for Ozempic (19:58 – 23:36).
Questions? Comments? Feedback? We’d love to hear from you! @roundstable
339 एपिसोडस
Manage episode 429602517 series 3323674
Welcome back Rounds Table Listeners!
In this throwback episode, Drs. Mike and John Fralick discuss the use of semaglutide in patients with obesity without diabetes and changes in renal function after starting dapagliflozin in patients with heart failure. Check it out below!
- Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial (0:00 – 09:40).
- Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (09:40 – 19:24).
And for the Good Stuff:
- How Ozempic and Weight Loss Drugs Are Reshaping Denmark’s Economy (19:24 – 19:58).
- How a Canadian scientist and a venomous lizard helped pave the way for Ozempic (19:58 – 23:36).
Questions? Comments? Feedback? We’d love to hear from you! @roundstable
339 एपिसोडस
Alle episoder
×प्लेयर एफएम में आपका स्वागत है!
प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।